224 related articles for article (PubMed ID: 16897430)
1. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines.
Paliouras M; Diamandis EP
Breast Cancer Res Treat; 2007 Mar; 102(1):7-18. PubMed ID: 16897430
[TBL] [Abstract][Full Text] [Related]
2. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract][Full Text] [Related]
3. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Luo LY; Grass L; Diamandis EP
Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187
[TBL] [Abstract][Full Text] [Related]
4. Human kallikrein 14: a new potential biomarker for ovarian and breast cancer.
Borgoño CA; Grass L; Soosaipillai A; Yousef GM; Petraki CD; Howarth DH; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 Dec; 63(24):9032-41. PubMed ID: 14695222
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.
Kulasingam V; Diamandis EP
Biol Chem; 2007 Oct; 388(10):1113-9. PubMed ID: 17937626
[TBL] [Abstract][Full Text] [Related]
6. Regucalcin is under-expressed in human breast and prostate cancers: Effect of sex steroid hormones.
Maia C; Santos C; Schmitt F; Socorro S
J Cell Biochem; 2009 Jul; 107(4):667-76. PubMed ID: 19347872
[TBL] [Abstract][Full Text] [Related]
7. Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals.
Slagter MH; Scorilas A; Gooren LJ; de Ronde W; Soosaipillai A; Giltay EJ; Paliouras M; Diamandis EP
Clin Chem; 2006 Aug; 52(8):1546-51. PubMed ID: 16777918
[TBL] [Abstract][Full Text] [Related]
8. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
[TBL] [Abstract][Full Text] [Related]
9. Human kallikrein 10, a predictive marker for breast cancer.
Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
[TBL] [Abstract][Full Text] [Related]
10. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases.
Komatsu N; Saijoh K; Toyama T; Ohka R; Otsuki N; Hussack G; Takehara K; Diamandis EP
Br J Dermatol; 2005 Aug; 153(2):274-81. PubMed ID: 16086736
[TBL] [Abstract][Full Text] [Related]
11. The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines.
Majumdar S; Diamandis EP
Br J Cancer; 1999 Mar; 79(9-10):1594-602. PubMed ID: 10188912
[TBL] [Abstract][Full Text] [Related]
12. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474.
Luo LY; Grass L; Diamandis EP
Anticancer Res; 2000; 20(2A):981-6. PubMed ID: 10810385
[TBL] [Abstract][Full Text] [Related]
13. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines.
Magklara A; Grass L; Diamandis EP
Breast Cancer Res Treat; 2000 Feb; 59(3):263-70. PubMed ID: 10832596
[TBL] [Abstract][Full Text] [Related]
14. Effect of cathepsin D and prostate specific antigen on latent transforming growth factor-beta in breast cancer cell lines.
Wong SF; Seow HF; Lai LC
Malays J Pathol; 2003 Dec; 25(2):129-34. PubMed ID: 16196369
[TBL] [Abstract][Full Text] [Related]
15. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.
Yousef GM; Obiezu CV; Luo LY; Black MH; Diamandis EP
Cancer Res; 1999 Sep; 59(17):4252-6. PubMed ID: 10485467
[TBL] [Abstract][Full Text] [Related]
16. Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions.
Black MH; Magklara A; Obiezu C; Levesque MA; Sutherland DJ; Tindall DJ; Young CY; Sauter ER; Diamandis EP
Br J Cancer; 2000 Jan; 82(2):361-7. PubMed ID: 10646889
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein gene downregulation in breast cancer.
Yousef GM; Yacoub GM; Polymeris ME; Popalis C; Soosaipillai A; Diamandis EP
Br J Cancer; 2004 Jan; 90(1):167-72. PubMed ID: 14710225
[TBL] [Abstract][Full Text] [Related]
18. Inhibition profiles of human tissue kallikreins by serine protease inhibitors.
Luo LY; Jiang W
Biol Chem; 2006 Jun; 387(6):813-6. PubMed ID: 16800745
[TBL] [Abstract][Full Text] [Related]
19. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.
Yousef GM; Luo LY; Scherer SW; Sotiropoulou G; Diamandis EP
Genomics; 1999 Dec; 62(2):251-9. PubMed ID: 10610719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
